IZURALIMAB

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 15:07:59 GMT 2023` Edited by `admin` on `Sat Dec 16 15:07:59 GMT 2023`
Protein Type	BISPECIFIC ANTIBODY
Protein Sub Type	IGG1
Sequence Origin	HUMANIZED MOUSE
Sequence Type	COMPLETE
Record UNII	9D2R4T39AY
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

IZURALIMAB

Official Name

English

IMMUNOGLOBULIN HALF-IG G1-KAPPA/SCFV-H-CH2-CH3, ANTI-(HOMO SAPIENS ICOS (INDUCIBLE T-CELL COSTIMULATORY, ACTIVATION-INDUCIBLE LYMPHOCYTE IMMUNOMEDIATORY MOLECULE, AILIM, CD278)) AND ANTI-(HOMO SAPIENS PDCD1 (PROGRAMMED CELL DEATH 1, PD-1, PD1, CD279)), M

Common Name

English

IZURALIMAB [USAN]

Common Name

English

IMMUNOGLOBULIN, ANTI-(HUMAN PROGRAMMED CELL DEATH 1) (HUMAN-MUS MUSCULUS MONOCLONAL XMAB23104 SINGLE-CHAIN VARIABLE FRAGMENT VL-LINKER-VH) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (HUMAN .GAMMA.1-CHAIN C-REGION C-TERMINAL FRAGMENT), (260->234'),(263->237')-

Common Name

English

izuralimab [INN]

Common Name

English

XMAB23104

Code

English

Izuralimab [WHO-DD]

Common Name

English

XMAB-23104

Code

English

Code System Code Type Description

NCI_THESAURUS

C157578